Prestige Consumer Healthcare Inc.
PBH
$86.97
-$1.07-1.22%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.14B | 1.12B | 1.11B | 1.11B | 1.13B |
| Total Other Revenue | 1.18M | 1.13M | 836.00K | 608.00K | 311.00K |
| Total Revenue | 1.14B | 1.12B | 1.11B | 1.11B | 1.13B |
| Cost of Revenue | 494.42M | 493.11M | 488.55M | 488.83M | 492.79M |
| Gross Profit | 643.35M | 625.12M | 622.11M | 624.36M | 632.57M |
| SG&A Expenses | 263.93M | 263.86M | 265.20M | 263.82M | 259.47M |
| Depreciation & Amortization | 30.17M | 30.76M | 31.54M | 31.26M | 30.68M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 788.52M | 787.74M | 785.29M | 783.91M | 782.93M |
| Operating Income | 349.24M | 330.50M | 325.37M | 329.28M | 342.43M |
| Income Before Tax | 284.19M | 277.55M | 266.97M | 265.73M | 276.03M |
| Income Tax Expenses | 69.58M | 63.62M | 61.02M | 60.59M | 66.69M |
| Earnings from Continuing Operations | 214.61 | 213.94 | 205.95 | 205.13 | 209.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 214.61M | 213.94M | 205.95M | 205.13M | 209.34M |
| EBIT | 349.24M | 330.50M | 325.37M | 329.28M | 342.43M |
| EBITDA | 379.41M | 361.26M | 356.91M | 360.54M | 373.10M |
| EPS Basic | 4.32 | 4.30 | 4.14 | 4.12 | 4.21 |
| Normalized Basic EPS | 3.73 | 3.49 | 3.35 | 3.34 | 3.47 |
| EPS Diluted | 4.30 | 4.27 | 4.11 | 4.09 | 4.17 |
| Normalized Diluted EPS | 3.70 | 3.46 | 3.33 | 3.31 | 3.44 |
| Average Basic Shares Outstanding | 198.79M | 198.97M | 199.11M | 199.15M | 199.03M |
| Average Diluted Shares Outstanding | 200.32M | 200.57M | 200.70M | 200.78M | 200.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |